Armata Pharmaceuticals (ARMP) Return on Invested Capital (2017)
Armata Pharmaceuticals (ARMP) has disclosed Return on Invested Capital for 1 consecutive years, with 0.76% as the latest value for Q4 2017.
- Quarterly Return on Invested Capital changed N/A to 0.76% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 0.76% through Dec 2017, changed N/A year-over-year, with the annual reading at 0.77% for FY2017, 122.0% up from the prior year.
- Return on Invested Capital hit 0.76% in Q4 2017 for Armata Pharmaceuticals.
- In the past five years, Return on Invested Capital ranged from a high of 0.76% in Q4 2017 to a low of 0.76% in Q4 2017.